Hoa Pham
About Hoa Pham
Hoa Pham is the Senior Director of Field HEOR at BeiGene, with over 20 years of experience in Health Economics and Outcomes Research.
Company: BeiGene
Hoa Pham joined BeiGene in August 2019 as the Senior Director of Field Health Economics and Outcomes Research (HEOR). With over 20 years of experience in HEOR, Hoa Pham brings extensive expertise to BeiGene, focusing on optimizing clinical and economic outcomes. The role involves high-level strategic planning and implementation of HEOR activities to support BeiGene's portfolio.
Title: Senior Director, Field HEOR
In the role of Senior Director, Field HEOR at BeiGene, Hoa Pham is responsible for leading health economics and outcomes research activities. This involves developing and executing strategies to demonstrate the value of BeiGene's products, ensuring they meet clinical and economic needs in the healthcare marketplace. This position capitalizes on Hoa Pham's vast experience in HEOR and managed markets.
Past Roles in Health Economics and Outcomes Research
Hoa Pham has held multiple significant roles across various companies in the field of Health Economics and Outcomes Research (HEOR). Key positions include Principal Clinical Value Outcomes at Seattle Genetics, Medical Science Director-Managed Markets, HEOR at ZS Pharma, Inc., and HEOR Lead at Hospira. These roles have equipped Hoa Pham with a diverse and comprehensive understanding of clinical value outcomes and managed markets.
Education and Expertise in Pharmacy and Pharmacoeconomics
Hoa Pham achieved a Doctor of Pharmacy (PharmD) from the University of Minnesota-Twin Cities and completed a Pharmacoeconomics Fellowship at The University of Texas at Austin. This strong educational background supports a deep expertise in pharmacoeconomics and healthcare outcomes, forming a solid foundation for a career in HEOR. The fellowship further specialized Hoa Pham's skills in managing healthcare costs and economic evaluation of pharmaceuticals.
Experience in Managed Markets and Clinical Value Outcomes
With significant roles in companies such as Seattle Genetics and ZS Pharma, Inc., Hoa Pham has developed a robust background in managed markets and clinical value outcomes. These roles involved strategic planning and execution to enhance the clinical and economic value of health products, which are crucial for successful market access and product reimbursement.